Ocimum Labs make high quality intermediates for global markets used by API manufacturers and fully integrated pharmaceutical companies. Ocimum Labs offers these intermediates at competitive prices adhering to the global standards including quality, GMP and documentation.


OFFERED INTERMEDIATES


  • Commercial

  • Under Development


S.No API Name Intermediates Name CAS Number Status
1 Flavoxate hydrochloride 3-Methylflavone-8-Carboxylic Acid 3468-01-7 Commercialised
2 Bilastine 2-(piperidin-4-yl)-1H-benzo[d]imidazole 38385-95-4 Commercialised
3 Bilastine 2-ethoxyethyl-4-methylbenzenesulfonate 17178-11-9 Commercialised
4 Bilastine 2-[4-(2-chloro-ethyl)-phenyl]-2-methyl-propionic acid methyl ester 1181267-33-3 Commercialised
5 Bilastine 1-(2-Ethoxyethyl)-2-(4-piperidinyl)-1H-benzimidazole hydrochloride 1841081-72-8 Commercialised
6 Bilastine 1-(2-Ethoxy-ethyl)-2-piperidin-4-yl-1H-benzimidazole 110963-63-8 Commercialised
7 Favipiravir 6-fluoro-3-hydroxypyrazine-2-carbonitrile dicyclohexylamine salt 1137606-74-6 Commercialised
8 Favipiravir 3-hydroxy-6-bromopyrazine-2-carboxamide 259793-88-9 Commercialised
9 Favipiravir 3,6-dichloropyrazine-2-carbonitrile 356783-16-9 Commercialised
10 Dronedarone Hydrochloride 5-Nitrosalicylaldehyde 97-51-8 Commercialised
11 Dronedarone Hydrochloride 2-n-Butyl-5-nitrobenzofuran 133238-87-6 Commercialised
12 Dronedarone Hydrochloride (2-butyl-5-nitrobenzofuran-3-yl)(4-hydroxyphenyl)methanone 141645-16-1 Commercialised
13 Dronedarone Hydrochloride 2-butyl-3-[4-(3-dibutylaminopropoxy)benzoyl]-5-nitrobenzofura 141645-23-0 Commercialised
14 Olmesartan 4-(1-Hydroxy-1-methylethyl)-2-propyl-1H-imidazole-5-carboxylic Acid Ethyl Ester) 144689-93-0 Commercialised
15 Olmesartan 2-propyl-1H-imidazole-4, 5-diethyl azodicarboxylate 144689-94-1 Commercialised
16 Paliperidone 3-(2-Chloroethyl)-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one 130049-82-0 Commercialised
17 Treprostinil 2-allyl-3-methoxybenzaldehyde 94956-98-6 Commercialised
18 Ticagrelor 5-Amino-4,6-dichloro-2-(propylthio)pyrimidine 145783-15-9 Commercialised
19 Ritonavir/Lopinavir (S,Z)-5-Amino-2-(dibenzylamino)-1,6-diphenylhex-4-en-3-one 156732-13-7 Commercialised
20 Sitagliptin phosphate monohydrate (2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihhyrdro[1,2,4] triazolo [4,3-a] pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl) butan-2-one 764667-65-4 Commercialised
21 DL-Dithiothreitol DL-Dithiothreitol 3483-12-3 Commercialised
22 2,2'-Bioxirane Diepoxybutane 1464-53-5 Commercialised
23 Silodosin 2-[2-(2,2,2-Trifluoroethoxy)phenoxy]ethyl methanesulfonate 160969-03-9 Under commercialization
24 Silodosin 5-[(2R)-2-Aminopropyl]-1-[3-(benzoyloxy)propyl]-2,3-dihydro-1H-indole-7-carbonitrile (2R,3R)-2,3-dihydroxybutanedioate 239463-85-5 Under commercialization
25 Silodosin 5-[(2R)-2-Aminopropyl]-2,3-dihydro-1-[3-(phenylmethoxy)propyl]-1H-indole-7-carbonitrile 459868-73-6 Under commercialization
26 Tamsulosin Hydrochloride 2-(2-Ethoxyphenoxy)ethyl Methanesulfonate 169506-15-4 Under commercialization
27 Tamsulosin Hydrochloride R-(-)-5-(2-Amino-propyl)-2-methoxy-benzenesulfonamide 112101-81-2 Under commercialization
28 Vildagliptin (2S)-1-(Chloroacetyl)-2-pyrrolidinecarbonitrile 207557-35-5 Under commercialization
29 Vildagliptin 3-amino-1-Adamantanol 702-82-9 Under commercialization
30 Imatinib 3-(dimethylamino)-1-(3-pyridyl)-2-propen-1-one 55314-16-4 Under commercialization
31 Imatinib N-(5-amino-2-methylphenl)-4-(3-pyridyl)-2-pyrimidine-amine 152460-10-1 Under commercialization
32 Imatinib 4-[(4-methyl-1-piperaziny)methyl]benzoic acid 106261-48-7 Under commercialization
33 Encorafenib 1-(3-iodo-1-isopropyl-1H-pyrazol-4-yl)ethanone 1269440-49-4 Under commercialization
34 New Intermediates 1,3-Adamantanediacetic acid 17768-28-4 Under development
35 New Intermediates 1,3-Adamantanediethanol 80121-65-9 Under development
36 New Intermediates 2-Chloro-5-hydroxypyridine 41288-96-4 Commercialised
37 New Intermediates 4-Methylresorcinol 496-73-1 Commercialised

CONNECT US